AAAAAA
Results:
1-16
|
Results: 16
Authors:
Robak, T
Kasznicki, M
Bartkowiak, J
Kordek, R
Wawrzyniak, E
Blonski, JZ
Citation: T. Robak et al., Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur, LEUK LYMPH, 42(4), 2001, pp. 789
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Citation: T. Robak et al., Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?, LEUK LYMPH, 41(5-6), 2001, pp. 545-557
Authors:
Robak, T
Robak, E
Bartkowiak, J
Blonski, JZ
Niewiadomska, H
Wawrzyniak, E
Citation: T. Robak et al., Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus, LEUK LYMPH, 41(5-6), 2001, pp. 659
Authors:
Robak, E
Niewiadomska, H
Robak, T
Bartkowiak, J
Blonski, JZ
Wozniacka, A
Pomorski, L
Sysa-Jedrzejowska, A
Citation: E. Robak et al., Lymphocytes T gamma delta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity, MEDIAT INFL, 10(4), 2001, pp. 179-189
Authors:
Robak, T
Gora-Tybor, J
Lech-Maranda, E
Blonski, JZ
Robak, T
Citation: T. Robak et al., Cladribine in combination with mitoxantrone and cyclophosphamide (CMC) in the treatment of heavily pre-treated patients with advanced indolent lymphoid malignancies, EUR J HAEMA, 66(3), 2001, pp. 188-194
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Gora-Tybor, J
Dwilewicz-Trojaczek, J
Boguradzki, P
Konopka, L
Ceglarek, B
Sulek, J
Kuliczkowski, K
Wolowiec, D
Stella-Holowiecka, B
Skotnicki, AB
Nowak, W
Moskwa-Sroka, B
Dmoszynska, A
Calbecka, M
Citation: T. Robak et al., Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia, LEUKEMIA, 15(10), 2001, pp. 1510-1516
Authors:
Robak, T
Kasznicki, M
Blonski, JZ
Dmoszynska, A
Skotnicki, AB
Citation: T. Robak et al., Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine, BR J HAEM, 112(4), 2001, pp. 1083-1085
Authors:
Jeziorski, A
Blonski, JZ
Niewiadomska, H
Citation: A. Jeziorski et al., The expression of products of oncogens c-erbB2 and EGFR and proliferating antigens Ki67 and PCNA in primary invasive ductal cancer of female breast, J EXP CL C, 19(1), 2000, pp. 61-67
Authors:
Niewiadomska, H
Mirowski, M
Stempien, M
Blonski, JZ
Czyz, W
Switalska, J
Matyga, E
Hanausek, M
Wierzbicki, R
Citation: H. Niewiadomska et al., Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients, NEOPLASMA, 47(1), 2000, pp. 8-14
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Konopka, L
Ceglarek, B
Dmoszynska, A
Soroka-Wojtaszko, M
Skotnicki, AB
Nowak, W
Dwilewicz-Trojaczek, J
Tomaszewska, A
Hellmann, A
Lewandowski, K
Kuliczkowski, K
Potoczek, S
Zdziarska, B
Hansz, J
Kroll, R
Komarnicki, M
Holowiecki, J
Grieb, P
Citation: T. Robak et al., Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients, BR J HAEM, 108(2), 2000, pp. 357-368
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Blasinska-Morawiec, M
Krykowski, E
Dmoszynska, A
Mrugala-Spiewak, H
Skotnicki, AB
Nowak, W
Konopka, L
Ceglarek, B
Maj, S
Dwilewicz-Trojaczek, J
Hellmann, A
Urasinski, I
Zdziarska, B
Kotlarek-Haus, S
Potoczek, S
Grieb, P
Citation: T. Robak et al., Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial, BLOOD, 96(8), 2000, pp. 2623-2629
Authors:
Robak, T
Blonski, JZ
Kasznicki, M
Blasinska-Morawiec, M
Krykowski, E
Dmoszynska, A
Mrugala-Spiewak, H
Skotnicki, AB
Nowak, W
Konopka, L
Ceglarek, B
Maj, S
Dwilewicz-Trojaczek, J
Heilmann, A
Urasinski, I
Zdziarska, B
Kotlarek-Haus, S
Potoczek, S
Grieb, P
Citation: T. Robak et al., Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial, BLOOD, 96(8), 2000, pp. 2723-2729
Authors:
Robak, T
Blasinska-Morawiec, M
Blonski, JZ
Dmoszynska, A
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia, LEUK LYMPH, 34(1-2), 1999, pp. 151-157
Authors:
Robak, T
Wierzbowska, A
Blasinska-Morawiec, M
Korycka, A
Blonski, JZ
Citation: T. Robak et al., Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission, MEDIAT INFL, 8(6), 1999, pp. 277-286
Authors:
Robak, E
Blonski, JZ
Bartkowiak, J
Niewiadomska, H
Sysa-Jedrzejowska, A
Robak, T
Citation: E. Robak et al., Circulating TCR gamma delta cells in the patients with systemic lupus erythematosus, MEDIAT INFL, 8(6), 1999, pp. 305-312
Authors:
Robak, T
Blonski, JZ
Urbanska-Rys, H
Blasinska-Morawiec, M
Skotnicki, AB
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger, LEUKEMIA, 13(4), 1999, pp. 518-523
Risultati:
1-16
|